These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE. Eur Heart J; 2008 Nov; 29(21):2625-33. PubMed ID: 18840879 [Abstract] [Full Text] [Related]
5. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511 [Abstract] [Full Text] [Related]
6. Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. Neil HA, Hawkins MM, Durrington PN, Betteridge DJ, Capps NE, Humphries SE, Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Atherosclerosis; 2005 Apr; 179(2):293-7. PubMed ID: 15777544 [Abstract] [Full Text] [Related]
7. Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome. Krasieva K, Gencer B, Locatelli I, Carballo D, Muller O, Fournier S, Matter CM, Räber L, Rodondi N, Mach F, Nanchen D. Circ Cardiovasc Qual Outcomes; 2024 Aug; 17(8):e010790. PubMed ID: 38899458 [Abstract] [Full Text] [Related]
8. Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records. Iyen B, Qureshi N, Weng S, Roderick P, Kai J, Capps N, Durrington PN, McDowell IF, Soran H, Neil A, Humphries SE. Atherosclerosis; 2020 Dec; 315():131-137. PubMed ID: 33187671 [Abstract] [Full Text] [Related]
15. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment. Farnier M, Civeira F, Descamps O, FH expert working group. Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482 [Abstract] [Full Text] [Related]
16. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia. Paquette M, Bernard S, Cariou B, Hegele RA, Genest J, Trinder M, Brunham LR, Béliard S, Baass A. Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300 [Abstract] [Full Text] [Related]
17. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. Tscharre M, Herman R, Rohla M, Piackova E, Vargas KG, Farhan S, Freynhofer MK, Weiss TW, Huber K. J Clin Lipidol; 2019 Oct; 13(1):115-122. PubMed ID: 30344049 [Abstract] [Full Text] [Related]
18. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Marks D, Thorogood M, Neil HA, Humphries SE. Atherosclerosis; 2003 May; 168(1):1-14. PubMed ID: 12732381 [Abstract] [Full Text] [Related]